Results of HPA Scoping Study
Released
Released
Announcement PDF
18 September 2025
Andromeda Metals Limited ASX: ADN
ASX Announcement
10/431 King William Street
Adelaide, SA 5000
Tel:+61 8 7089 9800
ir@andromet.com.au
ABN
75 061 503 375
HPA Scoping Study demonstrates market-leading economics of
Andromeda’s innovative technology
➢ Scoping Study justifies the commercialisation of Andromeda’s HPA production
technology using Great White kaolin feedstock
➢ Strong economic potential for Andromeda to become a leading global producer of
low-cost, low-carbon HPA
➢ Market-leading economics with low cost of production and capital expenditure
➢ HPA processing technology with lower-carbon emissions than traditional process
Cautionary Statement
The HPA Scoping Study referred to in this announcement has been undertaken in accordance with the
AusIMM Cost Estimation Handbook for feasibility studies, with the intention of announcing the outcomes to
support further investment and conversations with potential partners.
It is a preliminary technical and economic study of the potential viability of the HPA Project. It is based on
low level technical and economic assessments of the research and modelling that has been undertaken
to produce the HPA samples tested. The HPA samples were produced from preliminary test work using
batch processing. Actual recoveries and purity levels achieved through continuous processing may differ
significantly from those assumed.
Further evaluation work and appropriate studies are required before Andromeda will be in a position to
estimate detailed timing, capital and operating costs or to provide any assurance of an economic
development case. The HPA Scoping Study is based on the assumptions contained under the heading
Material Assumptions and Modifying Factors.
These include assumptions about the availability of funding. While Andromeda considers all of the material
assumptions to be based on reasonable grounds, there is no certainty that they will prove to be correct or
that the range of outcomes indicated by the Scoping Study will be achieved.
To achieve the range of outcomes indicated in the HPA Scoping Study, additional funding and feasibility
studies will be required to support the development of the HPA opportunity, in addition to the development
of the Great White Project proceeding and providing high-quality refined kaolin product as feedstock as
envisaged in the study.
Investors should note that there is no certainty that Andromeda will be able to raise the amount of funding
when needed. It is also likely that such funding may only be available on terms that may be dilutive to, or
otherwise affect, the value of Andromeda’s existing shares.
It is also possible that Andromeda could pursue other ‘value realisation’ strategies such as a sale, partial
sale or joint venture of the project. If it does, this could materially reduce Andromeda’s proportionate
ownership of the project.
Given the uncertainties involved, investors should not make any investment decisions based solely on the
results of this Scoping Study.
Andromeda Metals Limited (ASX: ADN) (Andromeda, the Company) is pleased to release the
outcomes of its Scoping Study (HPA Scoping Study), evaluating the economic potential of producing
High Purity Alumina (HPA) from its high quality Great White kaolin.
HPA is listed as a Critical Mineral in Australia 1, the US2 and Europe3 due to its strategic importance in
advanced technologies, growing use in energy applications and dependence on limited supply
chains.
The HPA Scoping Study demonstrates the strong economic potential for Andromeda to become a
leading global producer of low-cost, low-carbon HPA. This is underpinned by:
•
•
kaolin from the Great White Project (GWP) being ideally suited to producing HPA, being high
grade and having low levels of alkali metals and alkaline earth metals; and
recent test work results validating Andromeda’s novel process flowsheet and producing HPA
from kaolin to 99.9985% purity4.
The HPA Scoping Study provides a preliminary market, technical and economic review of the
opportunity and justifies the HPA Project (HPA Project, the Project) progressing towards development.
Key findings of the HPA Scoping Study5:
• HPA Processing Facility capable of producing 10,000 tpa of 4N HPA using ~30,000 tpa of GWP
kaolin as feedstock.
•
Net Present Value6 (NPV10) of approximately $1.48 billion (pre-tax) and $1.01 billion (post-tax)7.
•
Pre-production capital costs of approximately $155 million (inclusive of 30% contingency)8:
•
o
Market-leading capital intensity of $15,459 (US$9,894) per tonne of HPA capacity;
o
Significantly below other reported processes.
Operating costs of approximately $4,718 (US$3,020) per tonne:
o
Significantly below other globally reported processes;
o
Excludes any benefits from potential sales of amorphous silicate by-products.
• High product margin of 85%, equivalent to approximately $26,532 (US$16,980) per tonne using
conservative pricing assumptions of $31,250 (US$20,000) per tonne.
• Favourable market fundamentals with 20%9 compound annual growth rate (CAGR) of demand,
leading to an estimated supply shortfall of up to 78,071 tonnes in 2030, equivalent to 127% of
current available global production capacity9.
• Potential for Andromeda to become a global leader in the production of low-carbon HPA, with
modelling indicating 6.47 tonnes of carbon dioxide emissions per tonne of HPA (t-CO2/t-HPA)
using natural gas, which is 48% lower than the reported 12.44 t-CO2 / t-HPA of traditional
aluminium alkoxide process.10
1 HPA is included on the Australian Government’s Critical Minerals List: https://www.industry.gov.au/publications/australias-critical-minerals-list-and-
strategic-materials-list
2 HPA is included under Aluminium in the United States’ Critical Minerals List: https://www.usgs.gov/news/national-news-release/us-geological-survey-
releases-2022-list-critical-minerals
3 HPA and Aluminium have been merged under Bauxite in the European Union’s Critical Minerals List: https://single-market-
economy.ec.europa.eu/sectors/raw-materials/areas-specific-interest/critical-raw-materials_en
4 Refer to ADN ASX announcement dated 1 May 2025 titled Andromeda Achieves HPA Breakthrough: Successful Production of 4N HPA & Validation of Novel
Flow Sheet.
5 Australian dollars quoted, unless otherwise stated. USD/AUD exchange rate of 0.64 assumed. Figures are approximate, subject to rounding and should be
read in conjunction with Material Assumptions and Modifying Factors section (page 5).
Calculated using a discount rate of 10%.
Assumes company tax rate of 30%.
8
Excludes additional costs for PFS, marketing and other studies including ongoing test work, currently estimated to cost approximately $4 million.
9 High Purity Alumina Special Report 2023, CRU, October 2025.
10 White Paper – Green Credentials of Altech HPA Process, Altech Chemicals (Mar-2020).
6
7
Andromeda Metals Limited | 2
Key metrics and financial outcomes of the HPA Scoping Study11:
AUD
Target Production
USD
10,000 tpa
NPV10 (pre-tax)
$1,480 million
US$947 million
NPV10 (post-tax)12
$1,010 million
US$647 million
Revenue
$6,403 million
US$4,098 million
HPA Product Sale Price13
$31,250 / t
US$20,000 / t
Cash Operating Cost14
$4,718 / t
US$3,020 / t
Cash Operating Margin
$26,532 / t
US$16,980 / t
Cash Operating Margin (%)
85%
Average Annual EBITDA
$247 million
US$158 million
Pre-production Capital Cost15
$155 million
US$99 million
Capital Intensity16
$15,459 / t
US$9,894 / t
Sustaining Capital Cost
$114 million
US$73 million
IRR (pre-tax)17
88%
IRR (post-tax)
69%
Project Life18
24 years
Payback Period
3.2 years
Kaolin feedstock for the production of HPA is intended to be provided through an arms-length intercompany offtake agreement for refined kaolin product from Andromeda’s wholly owned Great White
Project (GWP), which is supported by Andromeda’s Ore Reserve of 15.1 Mt at the Great White
Deposit19.
The Company has determined that the outcomes of this Scoping Study warrant progressing the HPA
Project.
11 Australian dollars quoted, unless otherwise stated. USD/AUD exchange rate of 0.64 assumed. Figures are approximate, subject to rounding and should be
read in conjunction with Material Assumptions and Modifying Factors section (page 5).
10; assumes company tax rate of 30%.
13 Based HPA market analysis, which may not reflect actual offtake agreements entered into.
14 Excludes potential sales of silicate by-products.
15 Includes ~30% contingency, excludes additional costs for PFS, marketing and other studies including ongoing test work, currently estimated to take
approximately 2 years (subject to available funding) and cost approximately $4 million.
16 Calculated as Pre-production Capital Cost per tonne of HPA Target Production capacity.
17
Internal rate of return.
18
Nominal Project Life of 24-years modelled, including approximately 2 years of design and construction for a HPA Production Facility with a 22-year
production life.
19 Refer ADN ASX dated 6 April 2022 titled Great White Project DFS and Updated Ore Reserve. The 15.1 Mt Ore Reserves includes 5.1 Mt classed as Proven
and 10.0 Mt as Probable. Andromeda is not aware of any new information or data that materially affects the information included in this market
announcement and that all material assumptions and technical parameters underpinning the estimates continue to apply and have not materially change.
12 Post-tax NPV
Andromeda Metals Limited | 3
Sensitivity analysis (pre-tax)
The results show that the HPA Project’s value is most sensitive to the following changes:
•
AUD: USD exchange rate - A 20% reduction in AUD value increases NPV by 30%, a 20% increase
in AUD value decreases NPV by 20%.
•
Commodity prices - a 20% movement in HPA prices over the period of analysis increases or
reduces the NPV by 26%.
The Project’s value is less sensitive to the following changes:
•
Operating Costs - a 20% movement in total operating costs over the period of analysis increases
or decreases the NPV by 3%.
•
Capital Expenditure - a 20% movement in total capital costs over the period of analysis
increases or decreases the NPV by 3%.
2,400
2,200
Pre-tax NPV
2,000
1,800
1,600
1,400
1,200
1,000
800
-30%
-25%
-20%
-15%
-10%
-5%
0%
5%
10%
15%
20%
25%
30%
% Change
HPA Price
Opex
Capex
AUD:USD Exchange
Figure 1 Pre-tax NPV Sensitivity Analysis
Table 1 Pre-tax NPV Sensitivity Analysis
-30%
-20%
-10%
0%
10%
20%
30%
HPA Price (AUD)
900
1,094
1,287
1,480
1,673
1,866
2,059
Opex (AUD)
1,552
1,528
1,504
1,480
1,456
1,432
1,408
Capex (AUD)
1,539
1,519
1,499
1,480
1,460
1,441
1,421
AUD:USD Exchange
2,245
1,926
1,678
1,480
1,318
1,182
1,068
Andromeda Metals Limited | 4
140%
130%
Pre-tax IRR
120%
110%
100%
90%
80%
70%
60%
-30%
-25%
-20%
-15%
-10%
-5%
0%
5%
10%
15%
20%
25%
30%
% Change
HPA Price
Opex
Capex
AUD:USD Exchange
Figure 2 Pre-tax IRR Sensitivity Analysis
Table 2 Pre-tax IRR Sensitivity Analysis
-30%
-20%
-10%
0%
10%
20%
30%
HPA Price
63%
72%
80%
88%
96%
104%
111%
Opex
91%
90%
89%
88%
87%
86%
85%
Capex
115%
104%
95%
88%
82%
77%
72%
AUD: USD Exchange
98%
95%
91%
88%
85%
82%
80%
Funding
Approximately $159 million will be required to develop the HPA Project, based on the assumptions in
the HPA Scoping Study. This includes $155 million in Pre-production Capital Costs inclusive of ~30%
contingency, and approximately $4 million in additional costs for a Pre-Feasibility Study, including Plant
engineering design and refinement of capital and operating cost estimates, marketing and other
studies including ongoing test work.
The Company intends to seek equity investment initially to progress the HPA Project through
commercialisation and will likely target a combination of debt and equity for development funding.
Any available government grants or incentives, and other forms of investment, will also be
investigated. The Company also intends to actively seek offtake partners for HPA product once
commercial samples of HPA have been produced.
The Company has sought equity funding for the HPA Project to date, with some of the use of funds
from its $5million equity placement announced on 12 May 2025 allocated towards the HPA Project
(including the Scoping Study and product and market development activities).
The Company believe that there is a reasonable basis to assume that the additional funding required
to complete the forward work program and develop the HPA Project will be available on the following
basis:
• The Board and management team of Andromeda have a strong track record in developing
resources projects
Andromeda Metals Limited | 5
• The Company has a proven ability to attract new capital, both through equity and debt,
including in relation to the credit approval recently received for a A$75million project financing
facility to support the development of the Great White Project 20
• HPA is a high value critical mineral, with a significant supply shortfall predicted by 2030
• The Scoping Study demonstrates the HPA Project’s potential to deliver strong economic results
Next Steps
Next steps, subject to funding and approvals, include:
• Investigation of production and sales of 3N and 5N HPA products
• Establishment of a continuous pilot plant for process flow sheet optimisation and production of
commercial samples for potential customers
• Pre-feasibility and supporting studies
• Research into the potential value of silicate by-products.
Sarah Clarke, Andromeda’s Acting CEO said:
“The HPA Scoping Study demonstrates the exciting potential for Andromeda to become a global
producer of low-cost HPA products, using our low-carbon processing technology.
“The production of HPA is a high-value growth opportunity, which is not only complementary to the
existing high-quality kaolin products planned to be produced from the Great White Project, but would
also see Andromeda’s product range extend into critical minerals.
“The HPA Scoping Study supports progressing the HPA Project to the next stage, and demonstrates its
potential for unlocking significant value for Andromeda and its shareholders.”
This announcement has been approved for release by the Board of Andromeda Metals Limited.
For more information about the Company and its projects, please visit our website,
www.andromet.com.au or contact:
Manager, Investor Relations & Corporate Affairs
Patrick Sinclair
T: 08 7089 9819
M: 0403 708 431
E: Patrick.Sinclair@andromet.com.au
COMPETENT PERSONS STATEMENT
The data in the HPA Scoping Study that relates to Ore Reserve Estimates for the Great White Deposit is
based on, and fairly represent, information and supporting documentation fully reviewed and
understood by Mr Joseph Ranford who is a Fellow of the Australasian Institute of Mining and Metallurgy
(FAusIMM). Mr Ranford approves the Ore Reserve Estimates for the Great White Deposit. Mr Ranford is the
Chief Operating Officer of Andromeda Metal Limited and has sufficient experience relevant to the style
of mineralisation and type of deposit under consideration, and to the activity which he is undertaking, to
qualify as a Competent Person as defined in the 2012 Edition of the Australasian Code for Reporting of
Exploration Results, Mineral Resources and Ore Reserves (the “JORC Code”). Mr Ranford consents to the
information contained in this report being used in the form and context in which it appears. Mr Ranford
holds Shares and Performance Rights in the Company and is entitled to participate in Andromeda’s
employee incentive plan.
20
Refer to ADN ASX dated 4 June 2025 titled Credit Approved A$75 million Debt Facility.
Andromeda Metals Limited | 6
FORWARD-LOOKING STATEMENTS
This document contains or may contain certain forward-looking statements and comments about future
events, that are based on Andromeda's beliefs, assumptions and expectations and on information
currently available to management as at the date of this document. Often, but not always, forwardlooking statements can generally be identified by the use of forward-looking words such as "may", "will",
"expect", "plan", "believes", "estimate", "anticipate", "outlook", and "guidance", or similar expressions. Such
statements are only expectations or beliefs and are subject to inherent risks and uncertainties which
could cause actual values, results or performance achievements to differ materially from those expressed
or implied in this presentation. Where Andromeda expresses or implies an expectation or belief as to
future events or results, such expectation or belief is expressed in good faith and on a reasonable basis.
No representation or warranty, express or implied, is made by Andromeda that the matters stated in this
presentation will in fact be achieved or prove to be correct. Except as required by law, Andromeda
undertakes no obligation to provide any additional or updated information or update any forwardlooking statements, whether on a result of new information, future events, results or otherwise. Readers
are cautioned against placing undue reliance on forward-looking statements. These forward-looking
statements are not guarantees of future performance and involve known and unknown risks,
uncertainties, assumptions and other important factors, many of which are beyond the control of
Andromeda, the directors, and management of Andromeda.
INFORMATION DERIVED FROM THIRD PARTIES
Information in this document which is attributed to, or derived from, a third-party source has not been
independently checked or verified by Andromeda. No representation or warranty is made as to the
accuracy, completeness or reliability of such information.
This includes information from third parties pertaining to the HPA industry, forecast pricing, market
segments and end-markets in which Andromeda intends to operate (Market Data). Due to the forwardlooking nature of the Market Data, it may not necessarily reflect actual market conditions and there is no
guarantee that any forward-looking statements in the Market Data will prove to be correct or will be
achieved. Andromeda has not independently verified the Market Data and the Company cannot give
any assurances to the accuracy or completeness of this information or the underlying assumptions used
in generating this information. Industry assumptions, forecasts and estimates involve risks and uncertainties
and are subject to change based on various factors, including those discussed in the risk factors set out in
this presentation.
To the maximum extent permitted by law, neither Andromeda nor its related corporations, Directors,
officers, employees, advisers or agents, nor any other person, accepts any liability, including, without
limitation, any liability arising from the use of this document or its contents or otherwise arising in
connection with them, nor guarantees or makes any representations or warranties, express or implied, as
to or takes responsibility for, the currency, accuracy, reliability, completeness or fairness of the scoping
study or this document nor the information, opinions and conclusions contained in the scoping study or
this document
NO INVESTMENT OR FINANCIAL PRODUCT ADVICE
The information contained in this document does not constitute investment advice or financial product
advice (nor taxation or legal advice) and is not intended to be used as the basis for making an
investment decision or as a recommendation to acquire securities in Andromeda. The information
contained in this presentation should not be relied upon as a recommendation or forecast by
Andromeda (including as to the performance of Andromeda or its share price). Readers should obtain
their own professional advice and carry out their own independent investigations and assessment of the
information in this presentation (including any assumptions) before acting. An investment in Andromeda
is subject to investment and other known and unknown risks, some of which are beyond the control of
Andromeda including loss of income and principal invested. Any investment decision should be based
only on a person's own due diligence, inquiry, assessment and professional advice. Readers should have
regard to the Risk section on page 22 of the Executive Summary of the HPA Scoping Study (included in
this announcement) for further information about risks applicable to Andromeda and the HPA Project.
Andromeda Metals Limited | 7
Material Assumptions and Modifying Factors
This scoping study is aimed at providing a business overview and financial analysis of the proposed
production of 4N HPA using Andromeda’s proprietary technology.
The feedstock assumed for the HPA Processing Facility is defined in the Great White Ore Reserve
estimate, along with the published information in the updated Definitive Feasibility Study (2023 DFS).
Modifying factors relating to the feed are not listed here, rather this study relies on the refined kaolin
product sourced from the GWP.
The economic analysis relies on the following factors to build up the estimations:
21
•
The nameplate production capacity of the operation is 10,000 tonnes per annum of HPA
production with a minimum purity of 99.99% Al2O3 (4N), with a staged ramp up over 4 years to
reach full production (noting that this capacity has been determined based on market analysis,
but it should be noted that there is no guarantee that a facility of this scale will be constructed or
that full production will be achieved).
•
The HPA produced will meet the quality specifications required under any future customer
agreements.
•
The price of 4N HPA realised will be US$20,000 per tonne, which is conservative based on advice
provided by independent third-party market consultants.
•
The potential production and sale of 5N HPA products using Andromeda’s proprietary flowsheet
have not been included as a revenue stream in this model and remain an opportunity for the
project.
•
The Ore Reserve at Great White justifies an operation with a minimum mine life of 28 years21 For
the purposes of this HPA Scoping Study, a nominal 24-year project life has been modelled
(inclusive of approximately 2 years of design and construction for a HPA Production Facility with a
22-year production life).
•
The planned development of the Great White Project proceeds, enabling provision of highquality refined kaolin product as feedstock, as envisaged in the study.
•
Silicate by-products produced from the proprietary process have not been included as a revenue
stream in this model and remain an opportunity for the project.
•
A suitable site for the HPA Processing Facility can be found within South Australia with Great White
kaolin transported to the site.
•
No Native Title impediment exist in relation to the potential HPA Processing Facility sites.
•
No environmental impediments have been identified in relation to any of the HPA Processing
Facility sites.
•
Accuracy of data is to a Scoping Study accuracy (Class 5 estimate - 30%), as per AusIMM Cost
Estimation Handbook Second Edition Monograph 27.
•
A discount rate of 10% has been used.
•
A corporate tax rate of 30% has been assumed.
•
A USD / AUD exchange rate of 0.64 has been assumed.
•
No allowance has been made for the following items in the operating cost estimate:
o
Exchange rate variations
o
Escalation
o
Project financing costs
o
Interest charges
o
Utilisation of Andromeda’s existing carry-forward tax losses.
•
All goods and services tax (GST), import duties, surcharges and any other statutory taxation, levies
or government duties are excluded.
•
No allowance for contingency has been made in the operating cost estimates.
Refer to ADN ASX dated 24 August 2023 titled 2023 Definitive Feasibility Study Results; all material assumptions and
technical parameters underpinning the estimates and forecast financial information continue to apply and have not
materially changed.
Andromeda Metals Limited | 8
HPA Scoping Study
Executive Summary
September 2025
HPA Scoping Study - 2025
Overview
Andromeda Metals Limited (Andromeda, the Company) has prepared this Scoping Study
(HPA Scoping Study) as part of its business evaluation process for the commercial production
of High Purity Alumina (HPA) from kaolin (HPA Project, the Project). This HPA Scoping Study is
based on the construction and operation of a plant capable of producing a nominal 10,000
dry tonnes per annum (tpa) of HPA product in South Australia.
Over 7 years, the Company has undertaken investigation, research and metallurgical test
work leading to the development of a novel process flowsheet to produce HPA from kaolin
feedstock. Andromeda filed a Patent Co-operative Treaty (PCT) application for the novel
process in July 2022.
This HPA Scoping Study was commissioned following the successful undertaking of test work
on the novel process using refined kaolin product from the Company’s Great White Project
(GWP). Analysis conducted by EAG Eurofins USA confirmed the HPA produced from the test
work was 99.9985% pure, which was independently confirmed by analysis conducted by
Australia’s National Science Agency, the Commonwealth Scientific and Industrial Research
Organisation (CSIRO)1.
Once constructed and operational, the HPA Processing Facility will initially produce 2,500 dry
tpa HPA in year 1, increasing by 2,500 dry tpa each year to reach nominal production of
10,000 dry tpa in year 4. This staged strategy allows for the establishment of markets and
customer agreements with production growing to meet predicted growth in global demand.
Market advice from CRU Group (CRU)2 supports the proposed initial production of 2,500 dry
tpa, given it represents 3.1% of the global demand forecast for 4N+ HPA in 2027 of 79,799
tonnes, which is considered by Andromeda to be suitable for establishing a presence in the
existing market.
An assumed average pricing of USD20,000 per tonne for 4N HPA has been adopted by
Andromeda for this HPA Scoping Study (not escalated over time). This has been based on
market research which indicates current (2025) average 4N HPA prices range from
USD20,7003 per tonne up to USD30,7004 per tonne.
A future ramp-up of production to 10,000 tpa is considered appropriate, at the assumed
prices, based on market forecasts indicating it could be accommodated given predicted
market compound annual growth rates (CAGR) of 20.1% pa5, with a supply shortfall of 78,071
tonnes in 2030, equivalent to 127% of available capacity, as estimated by CRU.
This HPA Scoping Study outlines the potential economics of a HPA Processing Facility, that for
a capital investment of AUD155 million (inclusive of 30% contingency6) delivers a potential
1 Refer to ADN ASX dated 1 May 2025 titled Andromeda Achieves HPA Breakthrough: Successful Production of 4N
HPA & Validation of Novel Flow Sheet.
2 CRU Group is a private business intelligence firm specialising in mining, metals, and fertilisers, offering market
analysis, consulting, data services, and industry events globally.
3 High Purity Alumina Special Report 2023, CRU, October 2025.
4 High Purity Alumina Market Assessment, FutureBridge (commissioned by Andromeda), August 2025. FutureBridge is
a global techno-commercial consulting and advisory company that helps businesses anticipate and navigate the
future of their industries over a 1-to-25 year horizon.
5 High Purity Alumina Special Report 2023, CRU, October 2025.
6 On initial capital cost expenditure, but not capital spares.
Andromeda Metals Ltd
2
HPA Scoping Study - 2025
return of Net Present Value7 (NPV10) of ~AUD1,010 million post-tax, with an Internal Rate of
Return (IRR) of ~69% post-tax and a pay-back period of 3.2 years8. Average annual earnings
before interest depreciation and amortisation (EBITDA) of AUD247 million is predicted.
Sourcing high purity kaolin feedstock from Andromeda’s fully owned GWP is key to
producing HPA at a lower cost and lower environmental impact than other established
processes.
Currently, the largest producers of HPA rely on either the alkoxide hydrolysis process or a
modified Bayer process both of which use bauxite as the primary source of aluminium. These
processes are costly both economically and environmentally. Other companies are currently
investigating solutions away from aluminium metal with varying degrees of success.
Andromeda, however, is the first company to identify a commercial solution directly from
kaolin feedstock.
The Andromeda novel process presents an opportunity for low-cost, lower-carbon HPA
processing technology, with modelled carbon emissions up to 48% lower than the traditional
aluminium alkoxide process currently used in 88% of global HPA production9.
There is the potential to reduce carbon emissions further, through leveraging South Australia’s
leadership in renewable energy, which in 2024 generated more than 70% of its electricity
from renewables and has a target of reaching 100% net renewable energy by 202710.
It is considered that Andromeda’s proprietary technology has the potential to disrupt the
existing market by producing HPA sourced from kaolin, a more abundant and less costly
feedstock than feedstock used by established HPA processes.
Project Ownership
The HPA Project is held by Andromeda Technologies Holdings Pty Ltd (ATH), a wholly owned
subsidiary of Andromeda Metals Limited. Andromeda Metals Ltd is listed on the Australian
Securities Exchange (ASX) under the ticker code of ADN. The Great White Project is owned
by Andromeda Industrial Minerals Pty Ltd (AIM), another wholly owned subsidiary of
Andromeda Metals Ltd.
Project Location
A number of possible locations in South Australia (SA) (Figure 1) are being analysed against
key operational and infrastructure parameters, in particular reticulated gas supply. The
specific location of the processing facility has not yet been finalised.
Potential locations include Whyalla and industrial suburbs of northe
Share your feedback
Discover